About Oxoid
Oxoid is a Healthcare company based in Basingstoke (United Kingdom) founded in 1994, and was acquired by Fisher Scientific in February 2004. It operates as a microbiology products are developed for clinical and industrial applications. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Diversified. Its legal entity is OXOID A/S. Its competitors include Abcam, Stem Cell Technologies, OriGene, Sangon Biotech and Meridian Bioscience and 4 more; 5 of its 9 listed competitors have raised funding.
Company details
Oxoid was founded in 1994 in Basingstoke, United Kingdom, and focuses on the microbiology sector. Products for research, clinical, and industrial uses are produced, including agar, LB media, reagents, and culture consumables. The company was acquired by Thermo Fisher Scientific in 2004, integrating its operations into broader scientific instrumentation and supplies. Activities are centered in the UK with global distribution.
- Headquarters Basingstoke, United Kingdom
- Stage Acquired
- SectorsHealthcare
- Website oxoid.com
- Acquired by Fisher Scientific (Feb 2004)
- Legal Name Oxoid A/S
- Annual Revenue$1.57 M (USD)-74as on Dec 31, 2017
- Net Profit$3.31 M (USD)-4as on Dec 31, 2016
- Investors
- Acquired byFisher Scientific
(Feb 2004)
Investors in Oxoid
Oxoid has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Fisher Scientific.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Laboratory and production supplies and services are provided. | 1902 | fishersci.com | Hampton, United States |
Investor details for Oxoid
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Oxoid
2 dated milestones of Oxoid across 10 years, from founding to its latest funding, stage changes and deals.
- Founded Oxoid is founded.
- Exit Acquired by Fisher Scientific.
Competitors of Oxoid
Oxoid has 9 listed competitors in our database, 5 of them funded. They include Abcam, Stem Cell Technologies, OriGene, Sangon Biotech and Meridian Bioscience, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| abcam.com | 1998 | Cambridge, United Kingdom | $78.8M | 405 | Biological reagents and antibodies are developed for life science research. | |
| stemcell.com | 1993 | Vancouver, Canada | $11.92M | 129 | Developer of cell culture media and ancillary reagents for life science research | |
| origene.com | 1996 | Rockville, United States | $69.55M | 141 | Proteins, antibodies, and molecular tools are manufactured for research applications. | |
| sangon.com | 2003 | Shanghai, China | $300M | – | Research services, reagents, and kits for biotech applications are provided. | |
| meridianbioscience.com | 1976 | Ohio, United States | – | – | Molecular diagnostic device and kits | |
| teknova.com | 1996 | Hollister, United States | – | 290 | Molecular biology reagents and kits are supplied for research applications. | |
| caymanchem.com | 1980 | Ann Arbor, United States | – | 309 | Bioreagents and assay kits are developed, with preclinical services provided. | |
| abclonal.com | 2006 | Woburn, United States | $281.25M | – | Developer of protein and peptide reagents and kits for cell and molecular biology research | |
| seracare.com | 1984 | Milford, United States | – | – | Provider of biological materials/products that help optimize diagnostic performance, reliability and repeatability |
Detailed competitors of Oxoid
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Oxoid
Websites that share an audience with Oxoid (oxoid.com).
Websites whose visitors overlap most with Oxoid. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| neogen.com | 100% | 177.9K | #243,259 | View details | |
| labm.com | 92% | 2.1K | #9,614,299 | View details | |
himediadownloads.com | himediadownloads.com | 88% | – | #3,895,832 | – |
| mastgrp.com | 87% | – | – | View details | |
dalynn.com | dalynn.com | 83% | – | #1,816,829 | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 21 similar websites and full traffic analytics for Oxoid
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 21 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
10 companies that operate in the same segment as Oxoid (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | 1,111 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Oxoid
Complete news archive for Oxoid
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Oxoid
Oxoid was founded in 1994.
Oxoid is headquartered in Basingstoke, United Kingdom. It is registered at Basingstoke, Hampshire, United Kingdom.
Annual revenue of Oxoid is $1.57M as on Dec 31, 2017.
Oxoid was founded in 1994 in Basingstoke, United Kingdom, and focuses on the microbiology sector. Products for research, clinical, and industrial uses are produced, including agar, LB media, reagents, and culture consumables. The company was acquired by Thermo Fisher Scientific in 2004, integrating its operations into broader scientific instrumentation and supplies. Activities are centered in the UK with global distribution.
Oxoid's top competitors include Abcam, Meridian Bioscience and Stem Cell Technologies.
Oxoid has 1 investor. Key investors include Fisher Scientific.
Oxoid operates through Oxoid A/S.
Yes. Oxoid was acquired by Fisher Scientific in February 2004.